−2.30 TWD
−61.54 M TWD
4.85 M TWD
About GNT BIOTECH & MEDICALS CORP
Sector
CEO
Chia Nan Chen
Website
Headquarters
Taipei
Founded
2013
ISIN
TW0007427007
FIGI
BBG006H3JH85
Great Novel Therapeutics Biotech & Medicals Corp. engages in the research and development of cancer medical treatment. The company was founded by Chia Nan Chen on April 3, 2013 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7427 is 35.10 TWD — it has decreased by −2.09% in the past 24 hours. Watch GNT BIOTECH & MEDICALS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GNT BIOTECH & MEDICALS CORP stocks are traded under the ticker 7427.
7427 stock has fallen by −2.90% compared to the previous week, the month change is a −4.36% fall, over the last year GNT BIOTECH & MEDICALS CORP has showed a −47.59% decrease.
7427 reached its all-time high on Jun 21, 2023 with the price of 106.20 TWD, and its all-time low was 26.15 TWD and was reached on Jun 20, 2022. View more price dynamics on 7427 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7427 stock is 3.88% volatile and has beta coefficient of 0.34. Track GNT BIOTECH & MEDICALS CORP stock price on the chart and check out the list of the most volatile stocks — is GNT BIOTECH & MEDICALS CORP there?
Yes, you can track GNT BIOTECH & MEDICALS CORP financials in yearly and quarterly reports right on TradingView.
7427 net income for the last half-year is −61.96 M TWD, while the previous report showed −27.49 M TWD of net income which accounts for −125.37% change. Track more GNT BIOTECH & MEDICALS CORP financial stats to get the full picture.
No, 7427 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 12.00 employees. See our rating of the largest employees — is GNT BIOTECH & MEDICALS CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GNT BIOTECH & MEDICALS CORP EBITDA is −86.42 M TWD, and current EBITDA margin is −1.23 K%. See more stats in GNT BIOTECH & MEDICALS CORP financial statements.
Like other stocks, 7427 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GNT BIOTECH & MEDICALS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GNT BIOTECH & MEDICALS CORP technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GNT BIOTECH & MEDICALS CORP stock shows the sell signal. See more of GNT BIOTECH & MEDICALS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.